The anti-inflammatory pharmacology of Pycnogenol® in humans involves COX-2 and 5-LOX mRNA expression in leukocytes

International Immunopharmacology

Volumn 9, Issue 10, 2009, Pages 1145-1149

  Canali, Raffaella ^a   Comitato, Raffaella ^a   Schonlau, Frank ^b   Virgili, Fabio ^a  

^a ISTITUTO NAZIONALE DELLA NUTRIZIONE   (Italy)

^b Horphag Research UK Ltd   (United Kingdom)

Author keywords

5 LOX; COX 2; Flavonoids; Gene expression

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; ARACHIDONIC ACID; CYCLOOXYGENASE 2; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LEUKOTRIENE DERIVATIVE; LIPOPOLYSACCHARIDE; MESSENGER RNA; PHOSPHOLIPASE A2; PROSTAGLANDIN DERIVATIVE; PYCNOGENOL; THROMBOXANE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STIMULATION; UPREGULATION;

ADULT; ANTI-INFLAMMATORY AGENTS; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACIDS; CELLS, CULTURED; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FEMALE; FLAVONOIDS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; NEUTROPHILS; PHOSPHOLIPASES A2; RNA, MESSENGER;

EID: 69249206625     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.06.001     Document Type: Article

References (32)

1. Martel-Pelletier J., Lajeunesse D., Reboul P., and Pelletier J.P. Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non steroidal anti-inflammatory drugs. Ann Rheum Dis 62 (2003) 501-509
2. Furst D.E. Pharmacology and efficacy of cyclooxygenase inhibitors. Am J Med 107 suppl (1999) 18S-26S
3. Hendersen R. The role of leukotrienes in inflammation. Ann Int Med 121 9 (1994) 684-697
4. Wenzel S.E. Arachidonic acid metabolites: mediators of inflammation in asthma. Pharmacotherapy 17 (1997) 3S-12S
5. Rohdewald P. A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology. Int J Clin Pharmacol Ther 40 4 (2002) 158-168
6. Karonen M., Hamalainen M., Nieminen R., Klika K.D., Loponen J., Ovcharenko V.V., et al. Phenolic extractives from the bark of Pinus sylvestris L. and their effects on inflammatory mediators nitric oxide and prostaglandin E2. J Agric Food Chem 52 25 (2004) 7532-7540
7. Belcaro G., Cesarone M.R., Rohdewald P., Ricci A., Ippolito E., Dugall M., et al. Prevention of venous thrombosis and thrombophlebitis in long-haul flights with Pycnogenol. Clin Appl Thromb Hemost 10 4 (2004) 373-377
8. Wang S., Tang D., Zaho Y., Gao G., Gao X., and Hu L. The effects of Pycnogenol on the microcirculation, platelet function and ischemic myocardium in patients with coronary artery diseases. Eur Bull Drug Res 7 (1999) 19-25
9. Schafer A., Chovanova Z., Muchova J., Sumegova K., Liptakova A., Durackova Z., et al. Inhibition of COX-1 and COX-2 activity by plasma of human volunteers after ingestion of French maritime pine bark extract (Pycnogenol). Biomed Pharmacother 60 1 (2006) 5-9
10. Hosseini S., Pishnamazi S., Sadrzadeh S.M., Farid F., Farid R., and Watson R.R. Pycnogenol in the management of asthma. J Med Food 4 4 (2001) 201-209
11. Lau B.H.S., Riesen S.K., Truong K.P., Lau E.W., Rohdewald P., and Barreta B.S. Pycnogenol as an adjunct in the management childhood asthma. J Asthma 41 8 (2004) 825-832
12. Grimm T., Chovanova Z., Muchova J., Sumegova K., Liptakova A., Durackova Z., et al. Inhibition of NF-kappaB activation and MMP-9 secretion by plasma of human volunteers after ingestion of maritime pine bark extract (Pycnogenol). J Inflamm (Lond) 3 (2006) 1
13. Goldberg D.M., Yan J., and Soleas G.J. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem 36 1 (2003) 79-87
14. Surette M.E., Dallaire N., Jean N., Picard S., and Borgeat P. Mechanisms of the priming effect of lipopolysaccharides on the biosynthesis of leukotriene B4 in chemotactic peptide-stimulated human neutrophils. Faseb J 12 14 (1998) 1521-1531
15. Gasser O., and Schifferli J.A. Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis. Blood 104 (2004) 2543-2548
16. Lukiw W.J., and Bazan N.G. Cyclooxygenase 2 RNA message abundance, stability, and hypervariability in sporadic Alzheimer neocortex. J Neurosci Res 50 6 (1997) 937-945
17. Chan B.S., Satriano J.A., Pucci M., and Schuster V.L. Mechanism of prostaglandin E2 transport across the plasma membrane of HeLa cells and Xenopus oocytes expressing the prostaglandin transporter "PGT". J Biol Chem 273 12 (1998) 6689-6697
18. Abramovitz M., Wong E., Cox M.E., Richardson C.D., Li C., and Vickers P.J. 5-Lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase. Eur J Biochem 215 1 (1993) 105-111
19. Peters-Golden M., and Brock T.G. Intracellular compartmentalization of leukotriene synthesis: unexpected nuclear secrets. FEBS Lett 487 3 (2001) 323-326
20. Radmark O.P. The molecular biology and regulation of 5-lipoxygenase. Am J Respir Crit Care Med 161 2 Pt 2 (2000) S11-S15
21. Sala A., Bolla M., Zarini S., Muller-Peddinghaus R., and Folco G. Release of leukotriene A4 versus leukotriene B4 from human polymorphonuclear leukocytes. J Biol Chem 271 30 (1996) 17944-17948
22. Jala V.R., and Haribabu B. Leukotrienes and atherosclerosis: new roles for old mediator. Trends Immunol 25 6 (2004) 315-322
23. Kaminski W.E., Jendraschak E., Baumann K., Kiefl R., Fischer S., Marcus A.J., et al. Human mononuclear cells express 12-LX: coordinated mRNA regulation with 5-LX and FLAP genes. Blood 87 1 (1996) 331-340
24. Kaufmann W.E., Andreasson K.I., Isakson P.C., and Worley P.F. Cyclooxygenases and the central nervous system. Prostaglandins 54 3 (1997) 601-624
25. Secchiero P., Gonelli A., Ciabattoni G., Melloni E., Grill V., Rocca B., et al. TNF-related apoptosis-inducing ligand (TRAIL) up-regulates cyclooxygenase (COX)-1 activity and PGE(2) production in cells of the myeloid lineage. J Leukoc Biol 72 5 (2002) 986-994
26. Wallace J.L., Bak A., McKnight W., Asfaha S., Sharkey K.A., and MacNaughton W.K. Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity. Gastroenterology 115 1 (1998) 101-109
27. Tanabe T., and Tohnai N. Cyclooxygenase isozymes and their gene structures and expression. Prostaglandins Other Lipid Mediat 68-69 (2002) 95-114
28. Andreani M., Olivier J.L., Berenbaum F., Raymondjean M., and Bereziat G. Transcriptional regulation of inflammatory secreted phospholipases A(2). Biochim Biophys Acta 1488 1-2 (2000) 149-158
29. Ahn K.S., and Aggarwal B.B. Transcription factor NF-kappaB: a sensor for smoke and stress signals. Ann N Y Acad Sci 1056 (2005) 218-233
30. Choi S.H., Langenbach R., and Bosetti F. Cyclooxygenase-1 and -2 enzymes differentially regulate the brain upstream NF-kappa B pathway and downstream enzymes involved in prostaglandin biosynthesis. J Neurochem 98 3 (2006) 801-811
31. Peng Q., Wei Z., and Lau B.H. Pycnogenol inhibits tumor necrosis factor-alpha-induced nuclear factor kappa B activation and adhesion molecule expression in human vascular endothelial cells. Cell Mol Life Sci 57 5 (2000) 834-841
32. Peng Q., Wei Z., and Lau B.H. Pycnogenol inhibits tumor necrosis factor-alpha induced nuclear factor kappa B activation and adhesion molecule expression in human vascular endothelial cells. Cell Mol Life Sci 57 5 (2000) 834-841